-
Signature
-
/s/ David J. Corrsin, attorney-in-fact
-
Issuer symbol
-
AMRC
-
Transactions as of
-
10 Mar 2026
-
Net transactions value
-
-$6,910
-
Form type
-
4
-
Filing time
-
12 Mar 2026, 20:39:54 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Chiplock Mark |
EVP, CFO & CAO |
C/O AMERESCO, INC., 111 SPEEN STREET, SUITE 410, FRAMINGHAM |
/s/ David J. Corrsin, attorney-in-fact |
12 Mar 2026 |
0001755243 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
AMRC |
Class A Common Stock |
Options Exercise |
|
+750 |
+63% |
$0.000000* |
1,939 |
10 Mar 2026 |
Direct |
|
| transaction |
AMRC |
Class A Common Stock |
Sale |
$6,910 |
-273 |
-14% |
$25.31 |
1,666 |
12 Mar 2026 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
AMRC |
Stock Option (right to purchase) |
Award |
|
+20,000 |
|
$0.000000* |
20,000 |
10 Mar 2026 |
Class A Common Stock |
20,000 |
$26.36 |
Direct |
F2 |
| transaction |
AMRC |
Restricted Stock Unit |
Award |
|
+3,500 |
+156% |
$0.000000* |
5,750 |
10 Mar 2026 |
Class A Common Stock |
3,500 |
|
Direct |
F3, F4 |
| transaction |
AMRC |
Restricted Stock Unit |
Options Exercise |
|
-750 |
-13% |
$0.000000* |
5,000 |
10 Mar 2026 |
Class A Common Stock |
750 |
|
Direct |
F3, F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: